Koeleman B P, Reitsma P H, Bertina R M
Haemostasis and Thrombosis Research Centre, University Hospital Leiden, The Netherlands.
Semin Hematol. 1997 Jul;34(3):256-64.
Familial thrombosis has long been considered as an autosomal dominant trait, caused by a dominant gene defect with a reduced penetrance for the disease. Recently, this view has changed and today familial thrombophilia is considered as a complex genetic disorder caused by the segregation of two or more gene defects (known and unknown) in a family. Here we briefly discuss the known genetic defects (protein C, protein S, and antithrombin deficiency and activated protein C resistance associated with factor V Leiden) with special focus on the relation between gene mutation and plasma abnormality and on the association between abnormality and thrombosis in affected families and in the population. Finally, the evidence is reviewed that indicates familial thrombosis as an oligogenetic disorder and on the basis of these data strategies are discussed for the identification of new genetic risk factors for thrombosis via a genetic approach.
家族性血栓形成长期以来一直被视为一种常染色体显性性状,由显性基因缺陷导致,该疾病的外显率降低。最近,这种观点发生了变化,如今家族性血栓形成倾向被认为是一种复杂的遗传疾病,由家族中两个或更多基因缺陷(已知和未知)的分离引起。在此,我们简要讨论已知的遗传缺陷(蛋白C、蛋白S和抗凝血酶缺乏以及与因子V莱顿相关的活化蛋白C抵抗),特别关注基因突变与血浆异常之间的关系,以及受影响家族和人群中异常与血栓形成之间的关联。最后,对表明家族性血栓形成为寡基因疾病的证据进行了综述,并基于这些数据讨论了通过遗传方法识别血栓形成新遗传风险因素的策略。